Literature DB >> 25450667

Myricetin inhibits advanced glycation end product (AGE)-induced migration of retinal pericytes through phosphorylation of ERK1/2, FAK-1, and paxillin in vitro and in vivo.

Young Sook Kim1, Junghyun Kim2, Ki Mo Kim2, Dong Ho Jung2, Sojin Choi2, Chan-Sik Kim2, Jin Sook Kim3.   

Abstract

Advanced glycation end products (AGE) have been implicated in the development of diabetic retinopathy. Characterization of the early stages of diabetic retinopathy is retinal pericytes loss, which is the result of pericytes migration. In this study, we investigated the pathological mechanisms of AGE on the migration of retinal pericytes and confirmed the inhibitory effect of myricetin on migration in vitro and in vivo. Migration assays of bovine retinal pericytes (BRP) were induced using AGE-BSA and phosphorylation of Src, ERK1/2, focal adhesion kinase (FAK-1) and paxillin were determined using immunoblot analysis. Sprague-Dawley rats (6 weeks old) were injected intravitreally with AGE-BSA and morphological and immunohistochemical analysis of p-FAK-1 and p-paxillin were performed in the rat retina. Immunoblot analysis and siRNA transfection were used to study the molecular mechanism of myricetin on BRP migration. AGE-BSA increased BRP migration in a dose-dependent manner via receptor for AGEs (RAGE)-dependent activation of the Src kinase-ERK1/2 pathway. AGE-BSA-induced migration was inhibited by an ERK1/2 specific inhibitor (PD98059), but not by p38 and Jun N-terminal kinase inhibitors. AGE-BSA increased FAK-1 and paxillin phosphorylation in a dose- and time-dependent manner. These increases were attenuated by PD98059 and ERK1/2 siRNA. Phosphorylation of FAK-1 and paxillin was increased in response to AGE-BSA-induced migration of rat retinal pericytes. Myricetin strongly inhibited ERK1/2 phosphorylation and significantly suppressed pericytes migration in AGE-BSA-injected rats. Our results demonstrate that AGE-BSA participated in the pathophysiology of retinal pericytes migration likely through the RAGE-Src-ERK1/2-FAK-1-paxillin signaling pathway. Furthermore, myricetin suppressed phosphorylation of ERK 1/2-FAK-1-paxillin and inhibited pericytes migration.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Focal adhesion kinase-1; Migration; Myricetin; Paxillin; Retinal pericytes

Mesh:

Substances:

Year:  2014        PMID: 25450667     DOI: 10.1016/j.bcp.2014.09.022

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  10 in total

1.  Specific Inhibition of CYP4A Alleviates Myocardial Oxidative Stress and Apoptosis Induced by Advanced Glycation End-Products.

Authors:  Rui Wang; Li Wang; Jinlong He; Shanshan Li; Xiaojing Yang; Pengyuan Sun; Yuhui Yuan; Jinyong Peng; Jinsong Yan; Jianling Du; Hua Li
Journal:  Front Pharmacol       Date:  2019-08-09       Impact factor: 5.810

Review 2.  Targeting pericytes for neurovascular regeneration.

Authors:  Mohammad Hossein Geranmayeh; Reza Rahbarghazi; Mehdi Farhoudi
Journal:  Cell Commun Signal       Date:  2019-03-20       Impact factor: 5.712

3.  Role of Moesin Phosphorylation in Retinal Pericyte Migration and Detachment Induced by Advanced Glycation Endproducts.

Authors:  Shuang-Shuang Zhang; Jia-Qing Hu; Xiao-Hui Liu; Li-Xian Chen; Hong Chen; Xiao-Hua Guo; Qiao-Bing Huang
Journal:  Front Endocrinol (Lausanne)       Date:  2020-11-18       Impact factor: 5.555

4.  Spinach Methanolic Extract Attenuates the Retinal Degeneration in Diabetic Rats.

Authors:  Rocio Bautista-Pérez; Agustina Cano-Martínez; Elisa Gutiérrez-Velázquez; Martín Martínez-Rosas; Rosa M Pérez-Gutiérrez; Francisco Jiménez-Gómez; Javier Flores-Estrada
Journal:  Antioxidants (Basel)       Date:  2021-05-03

Review 5.  The Possible Role of Flavonoids in the Prevention of Diabetic Complications.

Authors:  Roberto Testa; Anna Rita Bonfigli; Stefano Genovese; Valeria De Nigris; Antonio Ceriello
Journal:  Nutrients       Date:  2016-05-20       Impact factor: 5.717

6.  Cell surface expression of nucleolin mediates the antiangiogenic and antitumor activities of kallistatin.

Authors:  Xiao-Ping Huang; Xiao Wang; Xiao-Lan Xie; Gao-Ping Zhang; Feng-Jiao Lv; Wen-Ting Weng; Fei Qiu; Zhao-Fa Li; Jun-Sheng Lin; Yong Diao
Journal:  Oncotarget       Date:  2017-12-16

Review 7.  Phytochemicals: Target-Based Therapeutic Strategies for Diabetic Retinopathy.

Authors:  Amna Parveen; Jin Hyun Kim; Byeong Gyu Oh; Lalita Subedi; Zahra Khan; Sun Yeou Kim
Journal:  Molecules       Date:  2018-06-23       Impact factor: 4.411

Review 8.  Ethnoveterinary plants of Pakistan: a review.

Authors:  Muhammad Abdul Aziz; Amir Hasan Khan; Andrea Pieroni
Journal:  J Ethnobiol Ethnomed       Date:  2020-05-15       Impact factor: 2.733

9.  Inhibition of Sema4D/PlexinB1 signaling alleviates vascular dysfunction in diabetic retinopathy.

Authors:  Jie-Hong Wu; Ya-Nan Li; An-Qi Chen; Can-Dong Hong; Chun-Lin Zhang; Hai-Ling Wang; Yi-Fan Zhou; Peng-Cheng Li; Yong Wang; Ling Mao; Yuan-Peng Xia; Quan-Wei He; Hui-Juan Jin; Zhen-Yu Yue; Bo Hu
Journal:  EMBO Mol Med       Date:  2020-01-13       Impact factor: 12.137

Review 10.  The Benefits of Flavonoids in Diabetic Retinopathy.

Authors:  Ana L Matos; Diogo F Bruno; António F Ambrósio; Paulo F Santos
Journal:  Nutrients       Date:  2020-10-16       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.